Alcon AG | ALC - Ebitda


Alcon AG reported $795M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AstraZeneca USD 7.46B 2.3B Sep/2026
Bayer EUR 1.62B 529M Sep/2026
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 912M 76M Sep/2026
Fresenius Medical Care EUR 817M 26.66M Sep/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 505M 32M Sep/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.6B 69M Jun/2026
Novartis USD 8.62B 2.14B Sep/2026
Philips EUR 772M 138M Sep/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
Smith & Nephew USD 796M 139M Dec/2025
UCB EUR 1.6B 570M Dec/2025